Evidence map›Paper›PMID 38343378›Full record

ArticlePsychological medicine2024

20-year neurocognitive development following a schizophrenia spectrum disorder and associations with symptom severity and functional outcomes.

Marie Starzer, Helene Gjervig Hansen, Carsten Hjorthøj, Nikolai Albert, Kathryn E Lewandowski, Louise Birkedal Glenthøj, Merete Nordentoft

Abstract read
In one paragraph

Article in Psychological medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marie StarzerCopenhagen Research Center for Mental Health - CORE, Mental Health Center Copenhagen, Mental Health Services in the Capital Region, Copenhagen, Denmark.ORCID 0000-0002-2311-2887
Helene Gjervig HansenCopenhagen Research Center for Mental Health - CORE, Mental Health Center Copenhagen, Mental Health Services in the Capital Region, Copenhagen, Denmark.
Carsten HjorthøjCopenhagen Research Center for Mental Health - CORE, Mental Health Center Copenhagen, Mental Health Services in the Capital Region, Copenhagen, Denmark.
Nikolai AlbertCopenhagen Research Center for Mental Health - CORE, Mental Health Center Copenhagen, Mental Health Services in the Capital Region, Copenhagen, Denmark.
Kathryn E LewandowskiSchizophrenia and Bipolar Disorder Program, McLean Hospital, Belmont, MA, USA.
Louise Birkedal GlenthøjCopenhagen Research Center for Mental Health - CORE, Mental Health Center Copenhagen, Mental Health Services in the Capital Region, Copenhagen, Denmark.
Merete NordentoftCopenhagen Research Center for Mental Health - CORE, Mental Health Center Copenhagen, Mental Health Services in the Capital Region, Copenhagen, Denmark.

Funding

TrygFonden
6 · The paper itself

Abstract

backgroundCognitive deficits are a core feature of schizophrenia and are closely associated with poor functional outcomes. It remains unclear if cognitive deficits progress over time or remain stable. Determining patients at increased risk of progressive worsening might help targeted neurocognitive remediation approaches.

methodsThis 20-year follow-up study examined neurocognitive outcomes of 156 participants from the OPUS I trial. Neurocognition was assessed using the brief assessment of cognition in schizophrenia at the 10- and 20-year follow-up, allowing us to examine changes in neurocognition over ten years.

resultsWe found that 30.5% of patients had a declining course of neurocognition, 49.2% had a stable course of neurocognition and 20.3% experienced improvements in neurocognition. Good cognitive functioning at the 20-year follow-up was significantly associated with higher levels of social functioning (B 6.86, CI 4.71-9.02,

conclusionOur findings support the notion of different schizophrenia subtypes with varying trajectories. Neurocognitive impairment at the 20-year follow-up was associated with other poor outcomes, highlighting the importance of treatments aimed at improving neurocognition in patients with schizophrenia spectrum disorders.

Indexed as

Cognitive DysfunctionSchizophreniaAdultCognitionDisease ProgressionFemaleFollow-Up StudiesHumansMaleMiddle AgedNeuropsychological TestsSchizophrenic PsychologySeverity of Illness IndexYoung Adultcognitive functionearly specialized intervention servicesfirst-episode psychosislongitudinal studylong-term follow-up studiesOPUSschizophrenia

Identifiers

PMID38343378
PMCPMC11413361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.